Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02167204 · ClinicalTrials.gov registry record · NA
18F-FLT PET/CT in Measuring Cell Proliferation in Patients With Brain Tumors
A NA study, sponsored by University of Washington.
- Completed
- Registry status
- NA
- Development phase
- 9
- Enrollment target
NCT02167204 is a NA study that has completed, run by University of Washington. The registered enrollment target is 9 participants.
The verdict
NCT02167204, a NA study, has completed, sponsored by University of Washington.
- COMPLETED
- Registry status
- NA
- Development phase
- 9 participants
- Enrollment target
Study Summary
This pilot clinical trial studies fluorine F 18 fluorothymidine (FLT) positron emission tomography (PET)/computed tomography (CT) in measuring cell proliferation in patients with brain tumors. Comparing results of diagnostic procedures done before, during, and after treatment may help doctors measure tumor growth and plan the best treatment.
Interventions
- PROCEDURE Computed Tomography
- PROCEDURE Positron Emission Tomography
- RADIATION Fluorothymidine F-18
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 9 participants |
| Start Date | 2012-11 |
| Est. Completion | 2019-01-21 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02167204
The ClinicalTrials.gov registry entry for NCT02167204 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 9 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Washington, which has 1,048 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Computed Tomography is the first listed.
NCT02167204 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02167204 about?
NCT02167204 is a clinical study titled "18F-FLT PET/CT in Measuring Cell Proliferation in Patients With Brain Tumors". This pilot clinical trial studies fluorine F 18 fluorothymidine (FLT) positron emission tomography (PET)/computed tomography (CT) in measuring cell proliferation in patients with brain tumors. Comparing results of diagnostic procedures done before, during, and after treatment may help doctors measur...
What is the current status of trial NCT02167204?
This trial is currently completed. It is a NA study. The enrollment target is 9 participants. The study started on 2012-11. Estimated completion is 2019-01-21.
What interventions are being tested in trial NCT02167204?
The interventions under investigation include: Computed Tomography (PROCEDURE), Positron Emission Tomography (PROCEDURE), Fluorothymidine F-18 (RADIATION).
Who is sponsoring clinical trial NCT02167204?
This trial is sponsored by University of Washington, which has 1,048 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.